Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA92569
Max Phase: Preclinical
Molecular Formula: C30H40N2O7S2
Molecular Weight: 604.79
Molecule Type: Small molecule
Associated Items:
ID: ALA92569
Max Phase: Preclinical
Molecular Formula: C30H40N2O7S2
Molecular Weight: 604.79
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCS(=O)(=O)N1CCC(N2CCC(C3(c4ccc(S(=O)(=O)c5ccc6c(c5)OCO6)cc4)CCCO3)CC2)CC1
Standard InChI: InChI=1S/C30H40N2O7S2/c1-2-20-40(33,34)32-17-12-25(13-18-32)31-15-10-24(11-16-31)30(14-3-19-39-30)23-4-6-26(7-5-23)41(35,36)27-8-9-28-29(21-27)38-22-37-28/h4-9,21,24-25H,2-3,10-20,22H2,1H3
Standard InChI Key: PFZBZEAIVHQPHF-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 604.79 | Molecular Weight (Monoisotopic): 604.2277 | AlogP: 4.17 | #Rotatable Bonds: 8 |
Polar Surface Area: 102.45 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 7.39 | CX LogP: 3.08 | CX LogD: 2.79 |
Aromatic Rings: 2 | Heavy Atoms: 41 | QED Weighted: 0.44 | Np Likeness Score: -0.69 |
1. Boyle CD, Chackalamannil S, Chen LY, Dugar S, Pushpavanam P, Billard W, Binch H, Crosby G, Cohen-Williams M, Coffin VL, Duffy RA, Ruperto V, Lachowicz JE.. (2000) Benzylidene ketal derivatives as M2 muscarinic receptor antagonists., 10 (24): [PMID:11133078] [10.1016/s0960-894x(00)00553-9] |
2. Wu YJ, Meanwell NA.. (2021) Geminal Diheteroatomic Motifs: Some Applications of Acetals, Ketals, and Their Sulfur and Nitrogen Homologues in Medicinal Chemistry and Drug Design., 64 (14.0): [PMID:34213340] [10.1021/acs.jmedchem.1c00790] |
Source(1):